PREDIERI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 40.381
EU - Europa 30.232
AS - Asia 19.444
SA - Sud America 2.573
Continente sconosciuto - Info sul continente non disponibili 851
AF - Africa 504
OC - Oceania 184
Totale 94.169
Nazione #
US - Stati Uniti d'America 39.222
IT - Italia 14.032
SG - Singapore 6.372
GB - Regno Unito 5.002
CN - Cina 4.783
SE - Svezia 3.486
HK - Hong Kong 2.302
BR - Brasile 1.888
DE - Germania 1.784
VN - Vietnam 1.705
FI - Finlandia 1.242
FR - Francia 1.018
BD - Bangladesh 966
UA - Ucraina 804
RU - Federazione Russa 721
CA - Canada 634
KR - Corea 591
TR - Turchia 587
IN - India 553
NL - Olanda 412
ID - Indonesia 317
BG - Bulgaria 307
JP - Giappone 225
AR - Argentina 210
MX - Messico 210
ES - Italia 202
IE - Irlanda 192
CH - Svizzera 160
PL - Polonia 154
PK - Pakistan 147
AU - Australia 146
ZA - Sudafrica 146
IQ - Iraq 143
EC - Ecuador 116
IR - Iran 97
BE - Belgio 94
EG - Egitto 92
LT - Lituania 90
AT - Austria 86
MY - Malesia 84
VE - Venezuela 84
DK - Danimarca 81
CO - Colombia 78
BZ - Belize 77
AE - Emirati Arabi Uniti 72
CL - Cile 65
TH - Thailandia 56
CZ - Repubblica Ceca 55
PH - Filippine 54
PT - Portogallo 47
RO - Romania 46
SA - Arabia Saudita 46
UZ - Uzbekistan 46
MA - Marocco 45
PE - Perù 45
CR - Costa Rica 41
PY - Paraguay 41
TW - Taiwan 40
DZ - Algeria 37
GR - Grecia 37
NZ - Nuova Zelanda 37
TN - Tunisia 37
JM - Giamaica 36
JO - Giordania 36
NP - Nepal 35
IL - Israele 34
KE - Kenya 33
ET - Etiopia 27
AZ - Azerbaigian 23
BO - Bolivia 22
HN - Honduras 22
RS - Serbia 22
HU - Ungheria 21
GT - Guatemala 20
AL - Albania 19
DO - Repubblica Dominicana 19
NI - Nicaragua 19
TT - Trinidad e Tobago 19
NG - Nigeria 18
KZ - Kazakistan 17
UG - Uganda 16
UY - Uruguay 16
NO - Norvegia 15
EU - Europa 13
PA - Panama 13
SM - San Marino 13
SV - El Salvador 13
PR - Porto Rico 12
EE - Estonia 11
KW - Kuwait 11
OM - Oman 11
CY - Cipro 10
LV - Lettonia 10
SI - Slovenia 10
LB - Libano 9
SK - Slovacchia (Repubblica Slovacca) 9
AM - Armenia 8
BS - Bahamas 8
GE - Georgia 8
MT - Malta 8
Totale 93.155
Città #
Ashburn 5.379
Singapore 4.283
Santa Clara 3.378
Southend 3.321
San Jose 2.392
Fairfield 2.256
Hong Kong 2.219
Stockholm 1.812
Chandler 1.626
Woodbridge 1.604
Houston 1.586
Hefei 1.418
Jacksonville 1.376
Council Bluffs 1.247
Milan 1.158
Dearborn 1.131
Rome 1.030
Helsinki 941
Nyköping 888
Seattle 864
Ann Arbor 859
London 858
Beijing 850
Wilmington 822
Cambridge 695
New York 653
Los Angeles 649
Seoul 541
Ho Chi Minh City 525
The Dalles 518
Naples 433
Hanoi 385
Bologna 380
Munich 377
Chicago 342
Princeton 325
São Paulo 324
Lauterbourg 294
Buffalo 291
Modena 288
Sofia 287
Palermo 276
San Diego 259
Turin 257
Eugene 254
Dallas 245
Columbus 234
Shanghai 224
Jakarta 220
Redwood City 217
Moscow 214
Izmir 208
Toronto 208
Orem 197
Frankfurt am Main 195
Bari 187
Bremen 187
Florence 161
Boardman 152
Dublin 152
Catania 149
Tokyo 133
Padova 121
Phoenix 121
Verona 121
Parma 109
Atlanta 102
Montreal 101
Salt Lake City 101
Chennai 99
Fremont 99
Des Moines 98
Las Vegas 98
Warsaw 97
Johannesburg 94
Da Nang 87
Brooklyn 82
Genoa 82
Albuquerque 80
Guangzhou 78
Tampa 78
Brescia 77
Nuremberg 77
Amsterdam 75
Belize City 75
Haiphong 72
Falls Church 70
Denver 69
Mexico City 66
Mumbai 65
Pescara 62
Philadelphia 62
Dong Ket 61
Nanjing 61
Paris 61
Rio de Janeiro 61
San Francisco 60
Turku 59
Cagliari 57
Reggio Emilia 56
Totale 58.028
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 5.008
"Balanced translocation" T(3;11)(P21;Q13) in a lipoma from a girl with suspected MEN 1 Syndrome. 2.043
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.226
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.223
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 972
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 884
Gestione del Covid-19 in età pediatrica: documento di consenso 801
Effetti degli interferenti endocrini su crescita e sviluppo puberale 715
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 675
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 658
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 541
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 532
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 508
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 496
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 441
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 435
High basal serum allopregnanolone levels in overweight girls 434
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 432
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 421
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 407
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 407
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 403
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 403
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 400
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 400
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 399
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 398
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 398
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 394
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 392
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 390
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 390
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 389
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 388
Childhood obesity and environmental pollutants: a dual relationship 387
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 382
L’ipercolesterolemia familiare: terapia farmacologica 380
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 379
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 378
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 375
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 375
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 371
Brain-derived neurotrophic factor and epilepsy: a systematic review 355
Low serum allopregnanolone levels in girls with precocious pubarche 352
Approaches to dyslipidemia treatment in children and adolescents 348
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 348
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 348
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes 346
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 345
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 340
The Role of Nutrition on Thyroid Function 338
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 333
Endocrine immune-related adverse effects of immune-checkpoint inhibitors 330
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 328
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 324
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 321
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 319
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 318
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 318
COVID-19 and Type 1 Diabetes: Concerns and Challenges 317
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 317
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 314
Human amniotic epithelial cells (HAECs): a reliable source of insulin producing cells? 314
Obesity in pediatric age: The analysis of genomic rearrangements 313
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 312
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 310
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 309
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 308
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 307
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 306
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 305
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 304
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 303
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 302
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 302
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 301
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 301
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 300
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 298
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 295
Endocrine Disrupting Chemicals and Type 1 Diabetes 295
MicroRNAs change and target key regulatory genes involved in longitudinal growth in patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment 290
Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence 290
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 290
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 288
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 288
Low-density lipoprotein oxidizability in children with chronic renal failure 286
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 286
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency 286
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 285
Health-Related Quality of Life and Diabetes Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 285
Hypercholesterolemia in Childhood 284
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 283
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 282
Can inflammatory marker levels help in detecting early complications of childhood obesity? 282
Perinatal exposure to phthalates: From endocrine to neurodevelopment effects 280
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 280
A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes 280
Evaluation and management of hyperlipidemia in children and adolescents. 279
Extra Uterine Growth Restriction (EUGR) in very low birth weight infants: Growth recovery and neurodevelopment by the corrected age of 2 years old 279
Totale 45.277
Categoria #
all - tutte 305.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 305.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.725 0 0 0 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202515.136 572 469 440 1.066 2.521 2.130 1.193 874 1.973 920 1.335 1.643
2025/202628.565 1.631 972 2.031 2.832 3.901 2.037 3.590 1.304 3.980 2.516 2.041 1.730
2026/20277.806 1.168 1.962 2.901 1.775 0 0 0 0 0 0 0 0
Totale 94.169